Ronit Sharon

2.9k total citations
39 papers, 2.3k citations indexed

About

Ronit Sharon is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Ronit Sharon has authored 39 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in Ronit Sharon's work include Parkinson's Disease Mechanisms and Treatments (30 papers), Neurological disorders and treatments (9 papers) and Nuclear Receptors and Signaling (8 papers). Ronit Sharon is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (30 papers), Neurological disorders and treatments (9 papers) and Nuclear Receptors and Signaling (8 papers). Ronit Sharon collaborates with scholars based in Israel, United States and Germany. Ronit Sharon's co-authors include Dennis J. Selkoe, Ifat Bar-Joseph, Matthew P. Frosch, Virginie Loeb, Dominic M. Walsh, James A. Hamilton, Eitan Israeli, Jie Shen, Matthew S. Goldberg and Rebecca A. Betensky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ronit Sharon

39 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronit Sharon Israel 25 1.6k 806 795 726 367 39 2.3k
Melisa J. Baptista United States 9 1.6k 1.0× 994 1.2× 495 0.6× 899 1.2× 384 1.0× 10 2.4k
Chris McLendon United States 12 995 0.6× 1.0k 1.3× 1.1k 1.4× 602 0.8× 538 1.5× 16 2.6k
Elpida Tsika United States 20 1.3k 0.8× 662 0.8× 648 0.8× 513 0.7× 288 0.8× 25 1.9k
Sang Myun Park South Korea 29 938 0.6× 746 0.9× 649 0.8× 588 0.8× 593 1.6× 70 2.2k
Leigh J. Hsu United States 12 1.5k 0.9× 527 0.7× 750 0.9× 869 1.2× 367 1.0× 12 2.0k
Shusei Hamamichi United States 16 910 0.6× 943 1.2× 548 0.7× 453 0.6× 195 0.5× 31 2.2k
Christelle Guégan France 21 1.3k 0.8× 1.3k 1.6× 429 0.5× 813 1.1× 612 1.7× 25 2.8k
Hibiki Kawamata United States 28 1.3k 0.8× 1.6k 2.0× 652 0.8× 739 1.0× 303 0.8× 41 2.9k
Rili Ahmad United States 13 2.0k 1.3× 1.4k 1.7× 647 0.8× 928 1.3× 517 1.4× 14 3.0k
Hiroyo Yoshino Japan 26 1.7k 1.1× 741 0.9× 478 0.6× 985 1.4× 706 1.9× 62 2.3k

Countries citing papers authored by Ronit Sharon

Since Specialization
Citations

This map shows the geographic impact of Ronit Sharon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronit Sharon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronit Sharon more than expected).

Fields of papers citing papers by Ronit Sharon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronit Sharon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronit Sharon. The network helps show where Ronit Sharon may publish in the future.

Co-authorship network of co-authors of Ronit Sharon

This figure shows the co-authorship network connecting the top 25 collaborators of Ronit Sharon. A scholar is included among the top collaborators of Ronit Sharon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronit Sharon. Ronit Sharon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linetsky, Eduard, et al.. (2022). Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease. Frontiers in Neurology. 12. 716126–716126. 1 indexed citations
2.
Schechter, Meir, Jéssica Grigoletto, Hava Glickstein, et al.. (2020). A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease. Molecular Neurodegeneration. 15(1). 24–24. 20 indexed citations
3.
Schechter, Meir, et al.. (2020). α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate. Journal of Biological Chemistry. 295(52). 18076–18090. 35 indexed citations
4.
Grigoletto, Jéssica, et al.. (2019). α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls. Annals of Clinical and Translational Neurology. 6(12). 2426–2436. 35 indexed citations
5.
Franceschi, Giorgia De, Chiara Fecchio, Ronit Sharon, et al.. (2017). α-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in neuroprotection. Journal of Biological Chemistry. 292(17). 6927–6937. 28 indexed citations
6.
Grigoletto, Jéssica, et al.. (2017). Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss. Acta Neuropathologica Communications. 5(1). 37–37. 28 indexed citations
7.
Cooper, Garry, Alon Simchovitz, Ronit Sharon, et al.. (2015). Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus. Journal of Neurophysiology. 114(3). 1513–1520. 12 indexed citations
9.
Israeli, Eitan, et al.. (2014). Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids. Neurobiology of Disease. 70. 90–98. 45 indexed citations
10.
Loeb, Virginie, Yoav Biala, Shlomo Yehuda, et al.. (2011). α‐Synuclein Neuropathology is Controlled by Nuclear Hormone Receptors and Enhanced by Docosahexaenoic Acid in A Mouse Model for Parkinson's Disease. Brain Pathology. 22(3). 280–294. 53 indexed citations
11.
Loeb, Virginie, et al.. (2008). α‐Synuclein and Polyunsaturated Fatty Acids Promote Clathrin‐Mediated Endocytosis and Synaptic Vesicle Recycling. Traffic. 10(2). 218–234. 142 indexed citations
12.
Israeli, Eitan & Ronit Sharon. (2008). β‐Synuclein occurs in vivo in lipid‐associated oligomers and forms hetero‐oligomers with α‐synuclein. Journal of Neurochemistry. 108(2). 465–474. 35 indexed citations
13.
Haviv, Yaron, Dana Avrahami, Haim Ovadia, et al.. (2008). Induced Neuroprotection Independently From PrPSc Accumulation in a Mouse Model for Prion Disease Treated With Simvastatin. Archives of Neurology. 65(6). 762–75. 27 indexed citations
14.
Sharon, Ronit, Ifat Bar-Joseph, Gudrun Mirick, Charles N. Serhan, & Dennis J. Selkoe. (2003). Altered Fatty Acid Composition of Dopaminergic Neurons Expressing α-Synuclein and Human Brains with α-Synucleinopathies. Journal of Biological Chemistry. 278(50). 49874–49881. 156 indexed citations
15.
Sharon, Ronit, Ifat Bar-Joseph, Matthew P. Frosch, et al.. (2003). The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's Disease. Neuron. 37(4). 583–595. 463 indexed citations
16.
Schlossmacher, Michael G., Matthew P. Frosch, Wei Gai, et al.. (2002). Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies. American Journal Of Pathology. 160(5). 1655–1667. 255 indexed citations
18.
Daniel, Violet, Ronit Sharon, & Aaron Bensimon. (1989). Regulatory Elements Controlling the Basal and Drug-Inducible Expression of Glutathione S-Transferase Ya Subunit Gene. DNA. 8(6). 399–408. 26 indexed citations
19.
Daniel, Violet, et al.. (1988). 5'-Flanking sequence of mouse glutathione S-transferase Ya gene. Nucleic Acids Research. 16(1). 351–351. 21 indexed citations
20.
Daniel, Violet, et al.. (1987). Mouse Glutathione S-Transferase Ya Subunit: Gene Structure and Sequence. DNA. 6(4). 317–324. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026